LDLRAD3-PAMR1 Fusion FISH Probe
The LDLRAD3-PAMR1 Fusion FISH Probe is used to confirm a fusion of the LDLRAD3 and PAMR1 genes. The fusion of the LDLRAD3 and PAMR1 genes has been associated with Bladder Urothelial Carcinoma. These probes are FISH confirmed on normal peripheral blood in both interphase nuclei and metaphase spreads before shipment. Typical turnaround time for this product is 7-14 days after purchase.
** This product is for in vitro and research use only. This product is not intended for diagnostic use. Please note that both genes fall on the same chromosome and inter-chromosomal detection may be difficult to detect depending on the genes proximity to one another. Please consult our support staff before ordering this product to ensure that the probe can be designed to meet your specific needs.
| SKU | Test Kits | Buffer | Dye Color | Order Now |
|---|---|---|---|---|
| LDLRAD3-PAMR1-20-ORGR (Standard Design) | 20 (40 μL) | 200 μL |
|
|
| LDLRAD3-PAMR1-20-RERE | 20 (40 μL) | 200 μL |
|
|
| LDLRAD3-PAMR1-20-REOR | 20 (40 μL) | 200 μL |
|
|
| LDLRAD3-PAMR1-20-REGO | 20 (40 μL) | 200 μL |
|
|
| LDLRAD3-PAMR1-20-REGR | 20 (40 μL) | 200 μL |
|
|
| LDLRAD3-PAMR1-20-REAQ | 20 (40 μL) | 200 μL |
|
|
| LDLRAD3-PAMR1-20-ORRE | 20 (40 μL) | 200 μL |
|
|
| LDLRAD3-PAMR1-20-OROR | 20 (40 μL) | 200 μL |
|
|
| LDLRAD3-PAMR1-20-ORGO | 20 (40 μL) | 200 μL |
|
|
| LDLRAD3-PAMR1-20-ORAQ | 20 (40 μL) | 200 μL |
|
|
| LDLRAD3-PAMR1-20-GORE | 20 (40 μL) | 200 μL |
|
|
| LDLRAD3-PAMR1-20-GOOR | 20 (40 μL) | 200 μL |
|
|
| LDLRAD3-PAMR1-20-GOGO | 20 (40 μL) | 200 μL |
|
|
| LDLRAD3-PAMR1-20-GOGR | 20 (40 μL) | 200 μL |
|
|
| LDLRAD3-PAMR1-20-GOAQ | 20 (40 μL) | 200 μL |
|
|
| LDLRAD3-PAMR1-20-GRRE | 20 (40 μL) | 200 μL |
|
|
| LDLRAD3-PAMR1-20-GROR | 20 (40 μL) | 200 μL |
|
|
| LDLRAD3-PAMR1-20-GRGO | 20 (40 μL) | 200 μL |
|
|
| LDLRAD3-PAMR1-20-GRGR | 20 (40 μL) | 200 μL |
|
|
| LDLRAD3-PAMR1-20-GRAQ | 20 (40 μL) | 200 μL |
|
|
| LDLRAD3-PAMR1-20-AQRE | 20 (40 μL) | 200 μL |
|
|
| LDLRAD3-PAMR1-20-AQOR | 20 (40 μL) | 200 μL |
|
|
| LDLRAD3-PAMR1-20-AQGO | 20 (40 μL) | 200 μL |
|
|
| LDLRAD3-PAMR1-20-AQGR | 20 (40 μL) | 200 μL |
|
|
| LDLRAD3-PAMR1-20-AQAQ | 20 (40 μL) | 200 μL |
|
PAMR1 Gene Summary
The Peptidase Domain Containing Associated With Muscle Regeneration 1 (PAMR1) gene is located on chr11 :35453375-35547176 at 11p13.
Gene Name: Peptidase Domain Containing Associated With Muscle Regeneration 1
Chromosome: CHR11: 35453375 -35547176
Locus: 11p13
LDLRAD3 Gene Summary
The Low Density Lipoprotein Receptor Class A Domain Containing 3 (LDLRAD3) gene is located on chr11 :35965611-36252841 at 11p13.
Gene Name: Low Density Lipoprotein Receptor Class A Domain Containing 3
Chromosome: CHR11: 35965611 -36252841
Locus: 11p13
Gene Diseases
The LDLRAD3 PAMR1 Fusion has been associated with the following diseases:
| Disease Name |
|---|
| Bladder Urothelial Carcinoma |
FISH Probe Protocols
| Protocol, Procedure, or Form Name | Last Modified | Download |
|---|